Keeping Track: First RMAT Approval On The Horizon; Big Weeks For Merck, Lilly And Celgene

 
• By Michael Cipriano, Brenda Sandburg, Bridget Silverman, and Jessica Merrill

The latest drug development news and highlights from our US FDA Performance Tracker.

Keeping Track Feature image

More from Product Reviews

More from Pink Sheet